Search research articles
Contact Us
Filters
Showing results (111-120 of 493) with videos related to
Page
of 50
Sort By:
Neurochemical Research
|
May 21, 2011
Serum glutamine synthetase has no value as a diagnostic biomarker for Alzheimer's disease
Yannick Vermeiren, Nathalie Le Bastard, Christopher M Clark, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 28, 1985
Guanidino compounds in plasma, urine and cerebrospinal fluid of hyperargininemic patients during therapy
B Marescau, I A Qureshi, P De Deyn, et al.
Neuropsychologia
|
May 23, 2001
Phonological agraphia following a focal anterior insulo-opercular infarction
P Marien, B A Pickut, S Engelborghs, et al.
Nephron
|
August 31, 2001
Biochemical, histological and behavioral consequences of nephrectomy in young and aged mice
M Al Banchaabouchi, B Marescau, R D'Hooge, et al.
Behavioural Brain Research
|
January 31, 2012
Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model
Inge Heulens, Charlotte D'Hulst, Debby Van Dam, et al.
Neurocase
|
September 2, 2011
Grammar disruption in a patient with Neuro-Sweet syndrome
Peter Mariën, Wim Tops, Roel Crols, et al.
Neurochemistry International
|
September 1, 1995
Guanidino compound levels in brain regions of non-dialyzed uremic patients
P P De Deyn, B Marescau, R D'Hooge, et al.
British Journal of Pharmacology
|
January 1, 1997
Selective block of N-methyl-D-aspartic acid (NMDA)-evoked whole-cell currents in mouse cultured spinal neurones by CGP 40116
R D'Hooge, A Raes, P P Van Bogaert, et al.
Monash Bioethics Review
|
April 27, 2020
Bioethical implications of end-of-life decision-making in patients with dementia: a tale of two societies
Jaime D Mondragón, Latife Salame-Khouri, Arnoldo S Kraus-Weisman, et al.
CNS Spectrums
|
March 4, 2005
APP23 mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder
Debby Van Dam, Ellen Vloeberghs, Dorothee Abramowski, et al.
Page
of 50
Search research articles
Search
Showing results (111-120 of 493) with videos related to
Sort By:
Page
of 50
Neurochemical Research
|
May 21, 2011
Serum glutamine synthetase has no value as a diagnostic biomarker for Alzheimer's disease
Yannick Vermeiren, Nathalie Le Bastard, Christopher M Clark, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 28, 1985
Guanidino compounds in plasma, urine and cerebrospinal fluid of hyperargininemic patients during therapy
B Marescau, I A Qureshi, P De Deyn, et al.
Neuropsychologia
|
May 23, 2001
Phonological agraphia following a focal anterior insulo-opercular infarction
P Marien, B A Pickut, S Engelborghs, et al.
Nephron
|
August 31, 2001
Biochemical, histological and behavioral consequences of nephrectomy in young and aged mice
M Al Banchaabouchi, B Marescau, R D'Hooge, et al.
Behavioural Brain Research
|
January 31, 2012
Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model
Inge Heulens, Charlotte D'Hulst, Debby Van Dam, et al.
Neurocase
|
September 2, 2011
Grammar disruption in a patient with Neuro-Sweet syndrome
Peter Mariën, Wim Tops, Roel Crols, et al.
Neurochemistry International
|
September 1, 1995
Guanidino compound levels in brain regions of non-dialyzed uremic patients
P P De Deyn, B Marescau, R D'Hooge, et al.
British Journal of Pharmacology
|
January 1, 1997
Selective block of N-methyl-D-aspartic acid (NMDA)-evoked whole-cell currents in mouse cultured spinal neurones by CGP 40116
R D'Hooge, A Raes, P P Van Bogaert, et al.
Monash Bioethics Review
|
April 27, 2020
Bioethical implications of end-of-life decision-making in patients with dementia: a tale of two societies
Jaime D Mondragón, Latife Salame-Khouri, Arnoldo S Kraus-Weisman, et al.
CNS Spectrums
|
March 4, 2005
APP23 mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder
Debby Van Dam, Ellen Vloeberghs, Dorothee Abramowski, et al.
Page
of 50